What is OptimizeRx's market cap?

OptimizeRx (OPRX) has a market capitalization of $117.8M and trades on NASDAQ.

What is OptimizeRx's revenue and profitability?

OptimizeRx generated $107.3M in trailing twelve-month revenue with net income of $6.8M, representing a net margin of 6.4%. Gross margin stands at 70.0%, with free cash flow of $14.3M. These figures are based on the Q1 2026 filing.

Who are OptimizeRx's competitors?

OptimizeRx's key competitors include Doximity, GoodRx, Phreesia, and others. These companies compete in similar markets and product categories.

What subsidiaries does OptimizeRx have?

OptimizeRx's subsidiaries include Medicx Health, OptimizeRx d.o.o..

Where is OptimizeRx headquartered?

OptimizeRx is headquartered in United States of America and employs approximately 136 people. It has been publicly traded since 1996.

OptimizeRx

OPRX

OptimizeRx Corporation is a digital healthcare technology company that provides a point-of-care network and AI-driven marketing solutions for the life sciences industry.

Market cap

$117.84M-52.0%

Revenue$107.3M+39.8%

Net income$6.8M+144%

Free cash flow$14.3M+120%

EPS (diluted)$0.35+142%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 12, 2026

Revenue$19.8MBeat by $1.1M EPS$0.14Beat by $0.13

Read the full report

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$20.2M

EPS estimate$0.11

Financials

Q1 2026

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation & ratios

Valuation

See full

Market cap$117.84M-52.0%

Enterprise value$121.39M-52.2%

P/E17.2×—

P/S1.1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Competitors

By market cap

Veeva Systems$30.8B-32.9%

Doximity$4.0B-64.8%

GoodRx Holdings, Inc.$995.7M-41.2%

Phreesia$668.8M-60.4%

PubMatic$629.8M+4.3%

National Research Corporation$489.3M+30.4%

OptimizeRx$117.8M-51.2%

Spectral AI, Inc.$54.7M-21.8%

By revenue growth

OptimizeRx+39.8%

Veeva Systems+16.3%

Phreesia+14.1%

Doximity+13.1%

GoodRx Holdings, Inc.-1.2%

National Research Corporation-1.9%

PubMatic-2.3%

Spectral AI, Inc.-43.5%

By net margin

Doximity30.4%-8.7pp

Veeva Systems28.37%+1.0pp

National Research Corporation8.6%-6.6pp

OptimizeRx6.37%+26.4pp

GoodRx Holdings, Inc.2.61%-1.0pp

Phreesia1.85%+11.7pp

PubMatic-2.51%-16.3pp

Spectral AI, Inc.-69.96%-20.5pp

Profile

OptimizeRx Corporation is a digital healthcare technology company that provides a point-of-care network and AI-driven marketing solutions for the life sciences industry. The company facilitates engagement between pharmaceutical brands, healthcare providers, and patients by delivering targeted medical information, affordability messaging, and clinical alerts directly within electronic health record workflows and across omnichannel digital platforms.

Competitive position

A leading provider of point-of-care digital communication solutions with a proprietary network reaching over two million U.S. healthcare providers.

GeographiesUnited States, Croatia

Customer segmentsPharmaceutical Companies, Life Sciences, Healthcare Providers

Business modelB2B, SaaS, Advertising-supported, Data-as-a-Service

SuppliersElectronic Health Record (EHR) vendors, ePrescribing (eRx) platforms, De-identified claims data providers, Cloud infrastructure providers

CustomersPharmaceutical manufacturers, Life sciences brands, Healthcare advertising agencies

CountryUnited States of America

Listed1996

Employees136.0

CEOStephen L. Silvestro

SectorHealthcare

IndustryMedical - Healthcare Information Services

Websiteoptimizerx.com

FilingsSEC EDGAR

Ask your AI about OptimizeRx.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's market cap?: OptimizeRx (OPRX) has a market capitalization of $117.8M and trades on NASDAQ.
What is OptimizeRx's revenue and profitability?: OptimizeRx generated $107.3M in trailing twelve-month revenue with net income of $6.8M, representing a net margin of 6.4%. Gross margin stands at 70.0%, with free cash flow of $14.3M. These figures are based on the Q1 2026 filing.
Who are OptimizeRx's competitors?: OptimizeRx's key competitors include Doximity, GoodRx, Phreesia, and others. These companies compete in similar markets and product categories.
What subsidiaries does OptimizeRx have?: OptimizeRx's subsidiaries include Medicx Health, OptimizeRx d.o.o..
Where is OptimizeRx headquartered?: OptimizeRx is headquartered in United States of America and employs approximately 136 people. It has been publicly traded since 1996.